Evidence map›Paper›PMID 32033262›Full record

ArticleCancers2020

Integrin α7 and Extracellular Matrix Laminin 211 Interaction Promotes Proliferation of Acute Myeloid Leukemia Cells and Is Associated with Granulocytic Sarcoma.

Nobuhiko Kobayashi, Tsukasa Oda, Makiko Takizawa, Takuma Ishizaki, Norifumi Tsukamoto, Akihiko Yokohama, Hisashi Takei, Takayuki Saitoh, Hiroaki Shimizu, Kazuki Honma and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Nobuhiko KobayashiDepartment of Hematology, Gunma University Graduate School of Medicine, Maebashi 371-8510, Japan.ORCID 0000-0002-3341-5566
Tsukasa OdaLaboratory of Molecular Genetics, The Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371-8510, Japan.
Makiko TakizawaDepartment of Hematology, Gunma University Graduate School of Medicine, Maebashi 371-8510, Japan.
Takuma IshizakiDepartment of Hematology, Gunma University Graduate School of Medicine, Maebashi 371-8510, Japan.
Norifumi TsukamotoOncology Center, Gunma University Hospital, Maebashi 371-8510, Japan.
Akihiko YokohamaBlood Transfusion Service, Gunma University Hospital, Maebashi 371-8510, Japan.
Hisashi TakeiDepartment of Hematology, Gunma University Graduate School of Medicine, Maebashi 371-8510, Japan.
Takayuki SaitohGraduate school of Health Science, Gunma University, Maebashi 371-8510, Japan.
Hiroaki ShimizuDepartment of Hematology, Gunma University Graduate School of Medicine, Maebashi 371-8510, Japan.
Kazuki HonmaGraduate school of Health Science, Gunma University, Maebashi 371-8510, Japan.
Kei Kimura-MasudaGraduate school of Health Science, Gunma University, Maebashi 371-8510, Japan.
Yuko KurodaGraduate school of Health Science, Gunma University, Maebashi 371-8510, Japan.
Rei IshiharaGraduate school of Health Science, Gunma University, Maebashi 371-8510, Japan.
Yuki MurakamiGraduate school of Health Science, Gunma University, Maebashi 371-8510, Japan.
Hirokazu MurakamiGraduate school of Health Science, Gunma University, Maebashi 371-8510, Japan.
Hiroshi HandaDepartment of Hematology, Gunma University Graduate School of Medicine, Maebashi 371-8510, Japan.
Gunma University · JPGunma University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) with granulocytic sarcoma (GS) is characterized by poor prognosis; however, its underlying mechanism is unclear. Bone marrow samples from 64 AML patients (9 with GS and 55 without GS) together with AML cell lines PL21, THP1, HL60, Kasumi-1, and KG-1 were used to elucidate the pathology of AML with GS. RNA-Seq analyses were performed on samples from seven AML patients with or without GS. Gene set enrichment analyses revealed significantly upregulated candidates on the cell surface of the GS group. Expression of the adhesion integrin α7 (ITGA7) was significantly higher in the GS group, as seen by RT-qPCR (p = 0.00188) and immunohistochemistry of bone marrow formalin-fixed, paraffin-embedded (FFPE) specimens. Flow cytometry revealed enhanced proliferation of PL21 and THP1 cells containing surface ITGA7 in the presence of laminin 211 and stimulated ERK phosphorylation; this effect was abrogated following ITGA7 knockdown or ERK inhibition. Overall, high ITGA7 expression was associated with poor patient survival (p = 0.0477). In summary, ITGA7 is highly expressed in AML with GS, and its ligand (laminin 211) stimulates cell proliferation through ERK signaling. This is the first study demonstrating the role of integrin α7 and extracellular matrix interactions in AML cell proliferation and extramedullary disease development.

Indexed as

acute myelogenous leukemiaextracellular matrixgranulocytic sarcomaintegrinlaminin

Identifiers

PMID32033262
PMCPMC7072541
OpenAlexW2994346748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.